Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$13.8 - $20.6 $317,400 - $473,800
-23,000 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$9.94 - $54.8 $69,580 - $383,600
-7,000 Reduced 23.33%
23,000 $15,000
Q4 2019

Feb 11, 2020

SELL
$29.6 - $49.4 $1.18 Million - $1.98 Million
-40,000 Reduced 57.14%
30,000 $69,000
Q3 2019

Nov 14, 2019

SELL
$39.2 - $63.2 $313,600 - $505,600
-8,000 Reduced 10.26%
70,000 $139,000
Q2 2019

Aug 16, 2019

BUY
$60.4 - $84.2 $483,200 - $673,600
8,000 Added 11.43%
78,000 $236,000
Q4 2018

Feb 07, 2019

BUY
$52.4 - $99.2 $1.57 Million - $2.98 Million
30,000 Added 75.0%
70,000 $218,000
Q3 2018

Nov 13, 2018

BUY
$94.0 - $193.8 $3.76 Million - $7.75 Million
40,000 New
40,000 $204,000

About Motus GI Holdings, Inc.


  • Ticker MOTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 2,996,840
  • Description
  • Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
More about MOTS
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.